Skip to content
The People's CodeSearch
Menu

Changes to the Code

S. 3159 · Preserving Patient Access to Long-Term Care Pharmacies Act ·

In committee · step 2 of 5

Sections are cited like “7 U.S.C. § 2012”: 7 of the , 2012.

42 U.S.C. § 1395w–104 Beneficiary protections for qualified prescription drug coverage

+27 −0Shown
More for 42 U.S.C. § 1395w–104
Read § 1395w–104Only this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 1860D–4(b)(1) of the Social Security Act (42 U.S.C. 1395w–104(b)(1)) is amended by adding at the end the following new subparagraph:(F) Long-term care pharmacy supply fees.— (i) Plan reimbursement to pharmacy.— (I) In general.— For plan years 2026 and 2027, for each specified prescription dispensed by a long-term care pharmacy to an enrollee during such plan year, each PDP sponsor of a prescription drug plan …

    The section already has a provision under this letter or number, so it would have two.

This bill puts a provision under a letter or number this section already uses, so the section would have two. The law has probably changed since the bill was written.

§ 1395w–104(b)Access to covered part D drugs(1)–(2)

Start of § 1395w–104 to (b)(1)(F)(iii) unchanged ·

(I) In general In the case where the Secretary determines that a PDP sponsor offering a prescription drug plan has violated the standards for reasonable and relevant contract terms and conditions under subparagraph (A)(ii) or the provisions of clause (i)(VIII) of this subparagraph, the Secretary may use authorities under sections 1395w–27(g) and 1395w–112(b)(3)(E) of this title to impose civil monetary penalties or other intermediate sanctions.

(II) Application of civil monetary penalties The provisions of section 1320a–7a of this title (other than subsections (a) and (b)) shall apply to a civil monetary penalty under this clause in the same manner as such provisions apply to a penalty or proceeding under section 1320a–7a(a) of this title.

(F) [inserted: Long-term care pharmacy supply fees.—]

(i) [inserted: Plan reimbursement to pharmacy.—]

(I) [inserted: In general.—] [inserted: For plan years 2026 and 2027, for each specified prescription dispensed by a long-term care pharmacy to an enrollee during such plan year, each PDP sponsor of a prescription drug plan and each MA organization offering an MA–PD plan shall pay such pharmacy a supply fee in an amount equal to—]

(aa) [inserted: for plan year 2026, $30; and]

(bb) [inserted: for plan year 2027, the amount of the supply fee for the prior plan year, increased by the annual percentage increase described in section 1860D–2(b)(6).]

(II) [inserted: Clarification.—] [inserted: The supply fee under this subparagraph shall be paid at the same time and in addition to any other pharmacy reimbursements, including ingredient costs, dispensing fees, or other payments negotiated between the PDP sponsor or MA organization and the long-term care pharmacy, and shall not result in a reduction to such other reimbursements.]

(ii) [inserted: Enforcement.—]

(I) [inserted: Civil money penalty.—] [inserted: The Secretary shall impose a civil money penalty on each PDP sponsor of a prescription drug plan and MA organization offering an MA–PD plan that fails to pay a supply fee for a specified prescription dispensed to an enrollee in accordance with this subparagraph for each such failure in an amount of not less than $10,000.]

(II) [inserted: Application.—] [inserted: The provisions of section 1128A (other than subsections (a) and (b)) shall apply to a civil money penalty under this clause in the same manner as such provisions apply to a penalty or proceeding under section 1128A(a).]

(iii) [inserted: Definitions.—] [inserted: In this subparagraph:]

(I) [inserted: Applicable maximum fair price eligible individual.—] [inserted: The term “applicable maximum fair price eligible individual” means, with respect to a specified prescription, a maximum fair price eligible individual who, with respect to such prescription, is described in section 1191(c)(2)(A).]

(II) [inserted: Long-term care pharmacy.—] [inserted: The term “long-term care pharmacy” means a pharmacy with a national provider identifier associated with taxonomy code 3336L0003X (or a successor code), as maintained by the National Uniform Claim Committee.]

(III) [inserted: Maximum fair price.—] [inserted: The term “maximum fair price” has the meaning given such term in section 1191(c)(3).]

(IV) [inserted: Maximum fair price eligible individual.—] [inserted: The term “maximum fair price eligible individual” has the meaning given such term in section 1191(c)(2).]

(V) [inserted: Specified prescription.—] [inserted: The term “specified prescription” means a covered part D drug dispensed by a long-term care pharmacy to an applicable maximum fair price eligible individual at the maximum fair price pursuant to section 1193(a)(3)(A).]

(2) Use of standardized technology

(A) In general The PDP sponsor of a prescription drug plan shall issue (and reissue, as appropriate) such a card (or other technology) that may be used by an enrollee to assure access to negotiated prices under section 1395w–102(d) of this title.

Rest of § 1395w–104 unchanged ·

42 U.S.C. § 1395w–115 Subsidies for part D eligible individuals for qualified prescription drug coverage

+5 −0Shown
More for 42 U.S.C. § 1395w–115
Read § 1395w–115Only this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 1860D–15 of the Social Security Act (42 U.S.C. 1395w–115) is amended by adding at the end the following new subsection:(i) Repayment of long-Term pharmacy supply fees.— (1) In general.— In addition to amounts otherwise payable under this section to a PDP sponsor of a prescription drug plan or an MA organization offering an MA–PD plan, for plan years 2026 and 2027, the Secretary shall provide the …

§ 1395w–115(h)–(i)

Start of § 1395w–115 to (h) unchanged ·

(1) In general In addition to amounts otherwise payable under this section to a PDP sponsor of a prescription drug plan or an MA organization offering an MA–PD plan, for plan year 2023, the Secretary shall provide the PDP sponsor or MA organization offering the plan subsidies in an amount equal to the aggregate reduction in cost-sharing and deductible by reason of the application of paragraph (8) or (9) of section 1395w–102(b) of this title for individuals under the plan during the year.

(2) Timing The Secretary shall provide a subsidy under paragraph (1), as applicable, not later than 18 months following the end of the applicable plan year.

(i) [inserted: Repayment of long-Term pharmacy supply fees.—]

(1) [inserted: In general.—] [inserted: In addition to amounts otherwise payable under this section to a PDP sponsor of a prescription drug plan or an MA organization offering an MA–PD plan, for plan years 2026 and 2027, the Secretary shall provide the PDP sponsor or MA organization offering the plan subsidies in an amount equal to the aggregate amount of supply fees paid by such sponsor or organization to long-term care pharmacies pursuant to section 1860D–4(b)(1)(F) during the plan year.]

(2) [inserted: Timing.—] [inserted: The Secretary shall provide a subsidy under paragraph (1), as applicable, not later than 18 months following the end of the applicable plan year.]

Step through the changes